Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses-Reference-Cited by-同舟云学术

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses

Published:2013-03 Issue:3 Volume:13 Page:324-335
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Smith Wendell,Tomasec Peter,Aicheler Rebecca,Loewendorf Andrea,Nemčovičová Ivana,Wang Eddie C.Y.,Stanton Richard J.,Macauley Matt,Norris Paula,Willen Laure,Ruckova Eva,Nomoto Akio,Schneider Pascal,Hahn Gabriele,Zajonc Dirk M.,Ware Carl F.,Wilkinson Gavin W.G.,Benedict Chris A.

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference65 articles.

1. Cytomegalovirus and the role of interferon in the expression of tumor necrosis factor-related apoptosis-inducing ligand in the placenta;Andrews;American journal of obstetrics and gynecology,2007

2. NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142;Ashiru;J. Virol.,2009

3. Apoptosis control by death and decoy receptors;Ashkenazi;Curr. Opin. Cell Biol.,1999

4. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor;Baillie;J. Virol.,2003

5. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target;Baryawno;J. Clin. Invest.,2011

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Time to Die: How Cytomegaloviruses Suppress Apoptosis, Necroptosis, and Pyroptosis;Viruses;2024-08-09

2. Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword;Frontiers in Transplantation;2024-06-10

4. HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation;Proceedings of the National Academy of Sciences;2023-11-27

5. Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?;Cell Communication and Signaling;2023-09-25